CONVERTIBLE NOTEConvertible Note • May 30th, 2023 • Axim Biotechnologies, Inc. • Pharmaceutical preparations • California
Contract Type FiledMay 30th, 2023 Company Industry JurisdictionFOR VALUE RECEIVED, the undersigned, Axim Biotechnologies, Inc., a Nevada corporation (“Debtor”), promises to pay to the order of [__________________________], a [______________________], or order (“Holder”), at the corporate offices of Holder, or such other place as Holder may designate in writing, the principal amount of [______________________________________________________] and 00/100 Dollars ($________), together with interest on the unpaid principal balance from time to time outstanding, computed on the basis of a three hundred sixty (360) day year and compounded on a yearly basis at a rate equal to Three and Three Quarter Percent (3.75%) per annum (the “Interest Rate”).
CONVERTIBLE NOTEConvertible Note • February 16th, 2022 • Axim Biotechnologies, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 16th, 2022 Company Industry JurisdictionFOR VALUE RECEIVED, the undersigned, Axim Biotechnologies, Inc., a Nevada corporation (“Debtor”), promises to pay to the order of [INVESTOR], [], or order (“Holder”), at the corporate offices of Holder, or such other place as Holder may designate in writing, the principal amount of [AMOUNT EQUAL TO FACE VALUE] and 00/100 Dollars ($_______), together with interest on the unpaid principal balance from time to time outstanding, computed on the basis of a three hundred sixty (360) day year and compounded on a yearly basis at a rate equal to Three Percent (3%) per annum (the “Interest Rate”).